Dimitri Talantov MD, PhD

Dmitri Talantov, M.D., is a medical leader with Janssen Clinical Innovation (JCI), a team within Janssen R&D whose mission is to improve efficiency and drive innovation for clinical trials. In this role, Dr. Talantov leads development of new clinical trial models, including direct-to-patient and hybrid trials, integration of the digital technology in clinical trials. Prior to joining JCI, Dr. Talantov served as a medical director with Janssen Healthcare Innovation, where he led evidence-generation efforts across its portfolio and worked to develop and implement integrated care solutions in commercial settings. Previously, he was also responsible for translational medicine components of early clinical development programs in immunology and in cardiovascular and metabolic therapeutic areas with Janssen R&D. He had also led multiple projects around molecular cancer diagnostics with the Medical Diagnostic & Devices sector of Johnson & Johnson. He was formerly an internal medicine physician for 10 years in Kazan, Russia. Dr. Talantov earned his medical degree at Kazan State Medical University in Russia and has received notable awards over the course of his career.